Risk factors associated with response to highly active antiretroviral therapy after 24 months of administration to HIV, HIV/HBV and HCV patients in Kumba Health District, South West Region of Cameroon

• Asıl Yazarlar: Adamu Ndongho Ndifontiayong (Yazar), Innocent Mbulli Ali (Yazar), Jean Baptiste Sokoudjou (Yazar), Karimo Ousenu (Yazar), Jerimiah Ndimumeh Mbogwe (Yazar), Ousenu Karimo (Yazar), Christopher Bonglavnyuy Tume (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Archives of Clinical Gastroenterology - Peertechz Publications, 2022-09-26.
• Konular: Case Study
• Online Erişim: Connect to this object online.

<p>Hepatitis B (HBV) and C (HCV) are two other forms of infections for which co-infection in HIV has been associated with alteration of the immune response,  increased risk of progression to liver diseases, and increased risk of hepatotoxicity associated with antiretroviral therapy. This study...